Clinical Trial: TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAWR)

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07765589) titled 'TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAWR)' on Aug. 06.

Brief Summary: This Phase 2, multicenter, randomized, double-blind, placebo-controlled master protocol study will evaluate the safety and efficacy of TU-100, adjunctive to an Enhanced Recovery After Surgery (ERAS) pathway, for accelerating gastrointestinal recovery following major abdominopelvic surgery. TU-100 will be evaluated in 2 surgical populations under a Master Protocol: 1. Subjects undergoing Radical Cystectomy (RC), 2.subjects undergoing Complex Abdominal Wall Reconstruction (CAWR).

Study Start Date: Dec., 2026

Study Type: INT...